Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites.
Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. For avoidance of any doubts and to make it easier, you may consider any links to external websites as sponsored links. Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

FROST & SULLIVAN NAMES APPIAN TOP 2018 DIGITAL TRANSFORMATION PLATFORM IN LIFE SCIENCES & PHARMACEUTICALS

Appian (NASDAQ:APPN) received Frost & Sullivan’s 2018 North American Digital Transformation Platform award in the Life Sciences & Pharmaceutical industry for its cloud-based, low-code software application platform. According to the independent analyst firm, ” Appian has ramped up its capabilities and demonstrated unmatched product leadership and customer value in the life sciences and pharmaceutical industry.”

“We recognize that digital transformation is top of mind for every executive in this industry,” said Evi Cohen, Vice President and Global Pharma and Life Sciences Industry Lead at Appian. “Appian addresses the industry’s top concerns while delivering substantial value. We help organizations quickly build and deploy powerful enterprise applications with security, compliance, and good practice GxP regulations woven into the fabric of the software.”

Frost & Sullivan highlights Appian’s unique product leadership. The report states Appian is “enabling not just one aspect of digital transformation, which is improving the customer experience, but rather being equally committed to increasing customer value by transforming their business operations through its cutting-edge BPM engine that automates and optimizes business workflows. The resulting volume of actionable insights leads to improved decision making, streamlined operations, and maximized operational performance.”

The report continues: “Appian has clearly enhanced the value proposition for its customers of today and tomorrow.” To download a complimentary copy of the Frost & Sullivan report, click here.

“We needed a new regulatory submission management platform that combined quality and compliance with the flexibility to bring each new drug to market as quickly as possible. With Appian, we have simplified our end to end business processes and created a single authoritative source of truth.” – Multinational Pharmaceutical Company

Frost & Sullivan’s Best Practices Awards recognize companies throughout a range of regional and global markets for superior leadership, technological innovation, customer service, and strategic product development. Frost & Sullivan’s industry analyst team benchmarks market participants and measures their performance through independent, primary interviews, and secondary industry research in order to evaluate and identify best practices.